Coppell Advisory Solutions’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$267K Buy
+4,045
New +$315K 0.03% 289

Other funds holding BBIO

Coppell Advisory Solutions's BBIO Position: Q3 2026 in Review

Coppell Advisory Solutions opened a new position in BridgeBio Pharma (BBIO) in Q3 2026: 4,045 shares worth $267K. The stake represents 0.03% of the portfolio and ranks #289 among its holdings.

469 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • Coppell Advisory Solutions held 4,045 shares of BridgeBio Pharma worth $267K as of Q3 2026.
  • BridgeBio Pharma was a new Coppell Advisory Solutions position in Q3 2026.
  • BridgeBio Pharma made up 0.03% of Coppell Advisory Solutions's portfolio in Q3 2026, its #289 holding.
  • 469 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on Coppell Advisory Solutions's 13F filing for Q3 2026, filed 16 Nov 2026.